Invenomic Capital Management LP trimmed its holdings in UiPath, Inc. (NYSE:PATH – Free Report) by 39.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 663,434 shares of the company’s stock after selling 434,705 shares during the period. Invenomic Capital Management LP owned 0.12% of UiPath worth $10,874,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently made changes to their positions in PATH. Noble Wealth Management PBC acquired a new position in UiPath during the fourth quarter valued at approximately $25,000. HighMark Wealth Management LLC acquired a new position in UiPath during the fourth quarter valued at approximately $25,000. Raleigh Capital Management Inc. acquired a new position in UiPath during the fourth quarter valued at approximately $26,000. TD Waterhouse Canada Inc. raised its position in UiPath by 1,270.8% during the fourth quarter. TD Waterhouse Canada Inc. now owns 1,782 shares of the company’s stock valued at $29,000 after purchasing an additional 1,652 shares in the last quarter. Finally, Atlas Capital Advisors Inc. acquired a new position in UiPath during the fourth quarter valued at approximately $37,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. BMO Capital Markets lowered their price objective on shares of UiPath from $14.00 to $13.00 and set a “market perform” rating for the company in a research report on Monday, June 1st. Mizuho lowered their price objective on shares of UiPath from $15.00 to $12.00 and set a “neutral” rating for the company in a research report on Thursday, March 12th. Wells Fargo & Company lowered their price objective on shares of UiPath from $14.00 to $13.00 and set an “equal weight” rating for the company in a research report on Thursday, March 12th. Morgan Stanley lowered their price objective on shares of UiPath from $17.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, May 29th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of UiPath in a research report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $13.87.
UiPath Stock Performance
NYSE PATH opened at $10.26 on Thursday. The firm’s fifty day moving average price is $10.70 and its two-hundred day moving average price is $12.67. The stock has a market cap of $5.32 billion, a PE ratio of 17.10, a PEG ratio of 1.34 and a beta of 0.96. UiPath, Inc. has a fifty-two week low of $9.20 and a fifty-two week high of $19.84.
UiPath (NYSE:PATH – Get Free Report) last posted its earnings results on Thursday, May 28th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. The firm had revenue of $418.38 million for the quarter, compared to analysts’ expectations of $397.54 million. UiPath had a net margin of 19.58% and a return on equity of 7.92%. The company’s revenue was up 17.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.11 earnings per share. As a group, sell-side analysts predict that UiPath, Inc. will post 0.38 earnings per share for the current fiscal year.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Featured Articles
- Five stocks we like better than UiPath
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
